People
Former Ogilvy and WPP executive, David Mayo has joined Verita Healthcare Group, a global provider of preventative, personalised healthcare and wellness clinics, as Group Sales and Marketing Director.
Avillion LLP announces the appointment of Dr Anders Gersel Pedersen as a Non-Executive Director of Bond 2 Development 2 GP, the General Partner of Bond Avillion 2, the Avillion entity that enters into the co-development agreements with pharma partners.
Global Blood Therapeutics, Inc. announced that on September 1, 2019, the compensation committee of GBT’s board of directors granted Eric Fink and 8 new employees options to purchase an aggregate of 47,600 shares of the company’s common stock with a per share exercise price of $45.98 and restricted stock units for an aggregate of 54,425 shares of the company’s common stock.
Auris Medical Holding Ltd. announced the appointment of Elmar Schärli, CPA, as new Chief Financial Officer, effective November 1, 2019.
Biopharma companies strengthen the C-suite and board of directors with these appointments.
Biofidelity Ltd announces it has secured £0.75 million seed financing, following its formation earlier this year.
Strengthening Azelis’ focus on application and formulation support
John Houston brings more than 30 years of experience in drug discovery and development in pharma and biotech as Cybrexa prepares to transition to become a clinical-stage company
Robocath announces that it has raised €5 million to support the rollout of its robotic platform in strategic European target markets.
Erin Duffy to lead the growth and oversight of CARB-X’s portfolio of antibiotics, diagnostics, vaccines and other life-saving products addressing antibacterial resistance on a global level
PRESS RELEASES